Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Total Tumor Volume on 18F-PSMA-1007 PET as Additional Imaging Biomarker in mCRPC Patients Undergoing PSMA-Targeted Alpha Therapy with 225Ac-PSMA-I&T.
Unterrainer LM, Beyer L, Zacherl MJ, Gildehaus FJ, Todica A, Kunte SC, Holzgreve A, Sheikh GT, Herlemann A, Casuscelli J, Brendel M, Albert NL, Wenter V, Schmidt-Hegemann NS, Kunz WG, Cyran CC, Ricke J, Stief CG, Bartenstein P, Ilhan H, Unterrainer M. Unterrainer LM, et al. Among authors: unterrainer m. Biomedicines. 2022 Apr 20;10(5):946. doi: 10.3390/biomedicines10050946. Biomedicines. 2022. PMID: 35625683 Free PMC article.
Longitudinal [18F]GE-180 PET Imaging Facilitates In Vivo Monitoring of TSPO Expression in the GL261 Glioblastoma Mouse Model.
Holzgreve A, Pötter D, Brendel M, Orth M, Weidner L, Gold L, Kirchner MA, Bartos LM, Unterrainer LM, Unterrainer M, Steiger K, von Baumgarten L, Niyazi M, Belka C, Bartenstein P, Riemenschneider MJ, Lauber K, Albert NL. Holzgreve A, et al. Among authors: unterrainer lm, unterrainer m. Biomedicines. 2022 Mar 22;10(4):738. doi: 10.3390/biomedicines10040738. Biomedicines. 2022. PMID: 35453488 Free PMC article.
Feasibility of [68Ga]Ga-FAPI-46 PET/CT for detection of nodal and hematogenous spread in high-grade urothelial carcinoma.
Unterrainer LM, Lindner S, Eismann L, Casuscelli J, Gildehaus FJ, Bui VN, Albert NL, Holzgreve A, Beyer L, Todica A, Brendel M, Cyran CC, Karl A, Stief CG, Ledderose ST, Unterrainer M, Bartenstein P, Wenter V, Kretschmer A. Unterrainer LM, et al. Among authors: unterrainer m. Eur J Nucl Med Mol Imaging. 2022 Aug;49(10):3571-3580. doi: 10.1007/s00259-022-05761-5. Epub 2022 Mar 24. Eur J Nucl Med Mol Imaging. 2022. PMID: 35325283 Free PMC article.
Combination of pre-treatment dynamic [18F]FET PET radiomics and conventional clinical parameters for the survival stratification in patients with IDH-wildtype glioblastoma.
Li Z, Holzgreve A, Unterrainer LM, Ruf VC, Quach S, Bartos LM, Suchorska B, Niyazi M, Wenter V, Herms J, Bartenstein P, Tonn JC, Unterrainer M, Albert NL, Kaiser L. Li Z, et al. Among authors: unterrainer lm, unterrainer m. Eur J Nucl Med Mol Imaging. 2023 Jan;50(2):535-545. doi: 10.1007/s00259-022-05988-2. Epub 2022 Oct 13. Eur J Nucl Med Mol Imaging. 2023. PMID: 36227357 Free PMC article.
Can Radiomics Provide Additional Information in [18F]FET-Negative Gliomas?
von Rohr K, Unterrainer M, Holzgreve A, Kirchner MA, Li Z, Unterrainer LM, Suchorska B, Brendel M, Tonn JC, Bartenstein P, Ziegler S, Albert NL, Kaiser L. von Rohr K, et al. Among authors: unterrainer lm, unterrainer m. Cancers (Basel). 2022 Oct 5;14(19):4860. doi: 10.3390/cancers14194860. Cancers (Basel). 2022. PMID: 36230783 Free PMC article.
68Ga-EMP-100 PET/CT-a novel method for non-invasive assessment of c-MET expression in non-small cell lung cancer.
Unterrainer LM, Todica A, Beyer L, Brendel M, Holzgreve A, Kauffmann-Guerrero D, Unterrainer M, Bartenstein P, Tufman A. Unterrainer LM, et al. Among authors: unterrainer m. Eur J Nucl Med Mol Imaging. 2023 Jan;50(2):628-629. doi: 10.1007/s00259-022-05995-3. Epub 2022 Oct 18. Eur J Nucl Med Mol Imaging. 2023. PMID: 36253641 Free PMC article. No abstract available.
The maximum standardized uptake value in patients with recurrent or persistent prostate cancer after radical prostatectomy and PSMA-PET-guided salvage radiotherapy-a multicenter retrospective analysis.
Spohn SKB, Farolfi A, Schandeler S, Vogel MME, Ruf J, Mix M, Kirste S, Ceci F, Fanti S, Lanzafame H, Serani F, Gratzke C, Sigle A, Combs SE, Bernhardt D, Gschwend JE, Buchner JA, Trapp C, Belka C, Bartenstein P, Unterrainer L, Unterrainer M, Eiber M, Nekolla SG, Schiller K, Grosu AL, Schmidt-Hegemann NS, Zamboglou C, Peeken JC. Spohn SKB, et al. Eur J Nucl Med Mol Imaging. 2022 Dec;50(1):218-227. doi: 10.1007/s00259-022-05931-5. Epub 2022 Aug 19. Eur J Nucl Med Mol Imaging. 2022. PMID: 35984452 Free PMC article.
Validation of the standardization framework SSTR-RADS 1.0 for neuroendocrine tumors using the novel SSTR‑targeting peptide [18F]SiTATE.
Ebner R, Lohse A, Fabritius MP, Rübenthaler J, Wängler C, Wängler B, Schirrmacher R, Völter F, Schmid HP, Unterrainer LM, Öcal O, Hinterberger A, Spitzweg C, Auernhammer CJ, Geyer T, Ricke J, Bartenstein P, Holzgreve A, Grawe F. Ebner R, et al. Among authors: unterrainer lm. Eur Radiol. 2024 May 20. doi: 10.1007/s00330-024-10788-3. Online ahead of print. Eur Radiol. 2024. PMID: 38769164
[68Ga]Ga-FAPI-46 PET/CT for penile cancer - a feasibility study.
Eismann L, Ledderose ST, Enzinger B, Berg E, Westhofen T, Rodler S, Schulz GB, Toms J, Holzgreve A, Gildehaus FJ, Brendel M, Cyran CC, Unterrainer M, Stief CG, Bartenstein P, Schlenker B, Unterrainer LM. Eismann L, et al. Among authors: unterrainer lm. Eur J Nucl Med Mol Imaging. 2024 May 18. doi: 10.1007/s00259-024-06763-1. Online ahead of print. Eur J Nucl Med Mol Imaging. 2024. PMID: 38761187
39 results